115 related articles for article (PubMed ID: 12083371)
1. Elongation factor 2 as a target for selective inhibition of protein synthesis in vitro by the novel aromatic bisamidine.
Gajko-Galicka A; Bielawski K; Sredzinska K; Bielawska A; Gindzienski A
Mol Cell Biochem; 2002 Apr; 233(1-2):159-64. PubMed ID: 12083371
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
Ahuja D; Vera MD; SirDeshpande BV; Morimoto H; Williams PG; Joullié MM; Toogood PL
Biochemistry; 2000 Apr; 39(15):4339-46. PubMed ID: 10757982
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protein synthesis inhibition by didemnin B in vitro.
SirDeshpande BV; Toogood PL
Biochemistry; 1995 Jul; 34(28):9177-84. PubMed ID: 7619818
[TBL] [Abstract][Full Text] [Related]
4. Ribosomes terminated in vitro are in a tight association with non-phosphorylated elongation factor 2 (eEF-2) and GDP.
Davydova EK; Malinin NL; Ovchinnikov LP
Eur J Biochem; 1993 Jul; 215(2):291-6. PubMed ID: 8344297
[TBL] [Abstract][Full Text] [Related]
5. Possibility of the transformation of eEF-2 (100 kDa) to eEF-2 (65 kDa) in the peptide elongation process in vitro.
Gajko A; Sredzińska K; Galasiński W; Gindzieński A
Biochem Biophys Res Commun; 1999 Feb; 255(2):535-8. PubMed ID: 10049743
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
Galicka A; Sredzińska K; Gindzieński A
Biochem Biophys Res Commun; 2000 Mar; 269(2):553-6. PubMed ID: 10708592
[TBL] [Abstract][Full Text] [Related]
7. EF-1 alpha is a target site for an inhibitory effect of quercetin in the peptide elongation process.
Marcinkiewicz C; Gałasiński W; Gindzieński A
Acta Biochim Pol; 1995; 42(3):347-50. PubMed ID: 8588487
[TBL] [Abstract][Full Text] [Related]
8. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
Nygård O; Nilsson L
Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of pentamidine analogues on protein biosynthesis in vitro.
Bielawski K; Galicka A; Bielawska A; Sredzińska K
Acta Biochim Pol; 2000; 47(1):113-20. PubMed ID: 10961684
[TBL] [Abstract][Full Text] [Related]
10. The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.
Obrig TG; Moran TP; Brown JE
Biochem J; 1987 Jun; 244(2):287-94. PubMed ID: 3663122
[TBL] [Abstract][Full Text] [Related]
11. The influence of selected potential oncostatics of plant origin on the protein biosynthesis in vitro.
Paszkiewicz-Gadek A; Chlabicz J; Gałasiński W
Pol J Pharmacol Pharm; 1988; 40(2):183-90. PubMed ID: 3237568
[TBL] [Abstract][Full Text] [Related]
12. Some properties and the possible role of intrinsic ATPase of rat liver 80S ribosomes in peptide bond elongation.
Ogata K; Ohno R; Terao K; Iwasaki K; Endo Y
J Biochem; 2000 Feb; 127(2):221-31. PubMed ID: 10731688
[TBL] [Abstract][Full Text] [Related]
13. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
Ergen K; Bektaş M; Gökçe S; Nurten R
Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
[TBL] [Abstract][Full Text] [Related]
14. Actin--an inhibitor of eukaryotic elongation factor activities.
Bektaş M; Günçer B; Güven C; Nurten R; Bermek E
Biochem Biophys Res Commun; 2004 May; 317(4):1061-6. PubMed ID: 15094376
[TBL] [Abstract][Full Text] [Related]
15. 2-Deoxyglucose and NMDA inhibit protein synthesis in neurons and regulate phosphorylation of elongation factor-2 by distinct mechanisms.
Maus M; Torrens Y; Gauchy C; Bretin S; Nairn AC; Glowinski J; Premont J
J Neurochem; 2006 Feb; 96(3):815-24. PubMed ID: 16405506
[TBL] [Abstract][Full Text] [Related]
16. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
Bektaş M; Nurten R; Ergen K; Bermek E
Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
[TBL] [Abstract][Full Text] [Related]
17. Adduct formation of 4-hydroxynonenal and malondialdehyde with elongation factor-2 in vitro and in vivo.
Argüelles S; Machado A; Ayala A
Free Radic Biol Med; 2009 Aug; 47(3):324-30. PubMed ID: 19447174
[TBL] [Abstract][Full Text] [Related]
18. The ageing heart: influence of cellular and tissue ageing on total content and distribution of the variants of elongation factor-2.
Jäger D; Holtz J; Redpath NT; Müller SP; Pönicke K; Heinroth-Hoffmann I; Werdan K; Müller-Werdan U
Mech Ageing Dev; 2002 Jul; 123(10):1305-19. PubMed ID: 12297334
[TBL] [Abstract][Full Text] [Related]
19. Ribosome-bound elongation factor 2 escapes phosphorylation by Ca2+/calmodulin-dependent protein kinase III.
Brigotti M; Sperti S; Carnicelli D; Montanaro L
Ital J Biochem; 1992; 41(3):195-9. PubMed ID: 1323554
[TBL] [Abstract][Full Text] [Related]
20. Effect of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 on translocation.
Montanaro L; Sperti S; Testoni G; Mattioli A
Biochem J; 1976 Apr; 156(1):15-23. PubMed ID: 182140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
